RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- Research and development, 2025
- $167M
- YoY, 2025
- −29.7%
- 5-year CAGR
- +13.1%
- 10-year CAGR
- +37.1%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $167M | −29.7% |
| 2024 | $238M | +76.3% |
| 2023 | $135M | +24.2% |
| 2022 | $109M | +4.3% |
| 2021 | $104M | +15.1% |
| 2020 | $90M | −17.4% |
| 2019 | $109M | +117.4% |
| 2018 | $50M | +119.9% |
| 2017 | $23M | +16.8% |
| 2016 | $20M | +174.1% |
| 2015 | $7.1M | — |